CLINICAL_TRIALS
trial_result
· 2014-06-24
Clinical Trial Update: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia. [Phase 2]
Summary
Completed Phase 2 clinical trial evaluating RO4917838 in combination with antipsychotic treatment for schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED